Literature DB >> 16119439

Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Jacques Gaillat1, Antoine Flahault, Bertille deBarbeyrac, Jeanne Orfila, Henri Portier, Jean-Pierre Ducroix, Christiane Bébéar, Charles Mayaud.   

Abstract

BACKGROUND: The role of Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) in lower respiratory tract infections (LRTI) is still little known in community settings.
METHODS: In all, 3207 adult cases of LRTI (871 with pneumonia, and 2336 with acute bronchitis) were prospectively included in the ETIIC1 ETIIC : ETude de l'Incidence des Infections respiratoires basses d'origine Communautaire dues A Chlamydia pneumoniae et Mycoplasma pneumoniae (Incidence of CP and MP in LRTI in community settings) program by 303 general practitioners and 24 hospital physicians in France between September 1997 and February 2000. The polymerase chain reaction and immunoassays were used to detect CP or MP in 3198 pharyngeal specimens obtained by gargling.
RESULTS: Of these 3198 patients, 232 (7.3%), were PCR-positive for CP and/or MP. Immunoassays were far less sensitive than PCRs (Se = 2 and 13% for MP and CP). Among the 2336 patients with acute bronchitis, PCR was positive for CP in 95 (4.1%), and for MP, in 54 (2.3%). Among the 671 patients with radiologically confirmed pneumonia, PCR was positive for CP in 23 (3.4%), and for MP in 49 (7.3%). CP and MP displayed significant geographic heterogeneity. Independent clinical determinants of positive PCR for CP and/or MP were age below 45 years, previous antimicrobial therapy (especially betalactams). Clinical signs were not of practical use in distinguishing accurately between etiologic diagnoses.
CONCLUSIONS: CP or MP diagnosed by PCR were found in more than 7% of patients with LRTI in community settings with a significant geographical heterogeneity and significant temporal trends in the incidence.

Entities:  

Mesh:

Year:  2005        PMID: 16119439     DOI: 10.1007/s10654-005-5868-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  36 in total

1.  Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.

Authors:  R W Peeling; S P Wang; J T Grayston; F Blasi; J Boman; A Clad; H Freidank; C A Gaydos; J Gnarpe; T Hagiwara; R B Jones; J Orfila; K Persson; M Puolakkainen; P Saikku; J Schachter
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

Review 2.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Authors:  S F Dowell; R W Peeling; J Boman; G M Carlone; B S Fields; J Guarner; M R Hammerschlag; L A Jackson; C C Kuo; M Maass; T O Messmer; D F Talkington; M L Tondella; S R Zaki
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

3.  [Acute respiratory Chlamydia pneumoniae infections in adults. Value of direct gene amplification diagnosis].

Authors:  F Vincent; J Petitjean; J E Filmont; G Le Moël; V Fontaine; A Vabret; F Freymuth; J Brun
Journal:  Rev Mal Respir       Date:  1999-12       Impact factor: 0.622

4.  Demonstration of Chlamydia pneumoniae in water used for gargling.

Authors:  A Oehme; J Roesler
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

5.  Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.

Authors:  C M Black; P I Fields; T O Messmer; B P Berdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

6.  Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group.

Authors:  S Ragnar Norrby
Journal:  J Antimicrob Chemother       Date:  1997-04       Impact factor: 5.790

7.  Regional differences of Chlamydia pneumoniae as causative agent of pneumonia in Sweden.

Authors:  P Kragsbjerg; K Persson; H Holmberg
Journal:  Scand J Infect Dis       Date:  1992

8.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

9.  Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction.

Authors:  B de Barbeyrac; C Bernet-Poggi; F Fébrer; H Renaudin; M Dupon; C Bébéar
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

10.  Mycoplasma pneumoniae infection in Hong Kong--clinical and epidemiological features during an epidemic.

Authors:  H S Hosker; J S Tam; C H Chain; C K Lai
Journal:  Respiration       Date:  1993       Impact factor: 3.580

View more
  6 in total

1.  Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR.

Authors:  Karolina Gullsby; Martin Storm; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

2.  Role of Atypical Pathogens and the Antibiotic Prescription Pattern in Acute Bronchitis: A Multicenter Study in Korea.

Authors:  Sunghoon Park; Kil Chan Oh; Ki-Seong Kim; Kyu-Tae Song; Kwang Ha Yoo; Yun Su Shim; Young Ju Lee; Myung Goo Lee; Jang Uk Yun; Hyun Su Kim; Yee Hyung Kim; Won Jun Lee; Do Il Kim; Hyung Gun Cha; Jae-Myung Lee; Jung San Seo; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

Review 3.  [Current epidemiology of microbial low respiratory tract infections].

Authors:  F Trémolières
Journal:  Med Mal Infect       Date:  2006-09-29       Impact factor: 2.152

Review 4.  Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.

Authors:  K Loens; H Goossens; M Ieven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-06       Impact factor: 3.267

5.  Efficacy of Jiedu Pingsou Decoction Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia and Its Effects on Inflammatory Factors and Immune Function.

Authors:  Shaoli Lin; Shiyun Wang; Juan Zhang; Min Zhuang; Zhen Meng; Jianhua Liu
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

6.  Severe atypical pneumonia in critically ill patients: a retrospective multicenter study.

Authors:  S Valade; L Biard; V Lemiale; L Argaud; F Pène; L Papazian; F Bruneel; A Seguin; A Kouatchet; J Oziel; S Rouleau; N Bele; K Razazi; O Lesieur; F Boissier; B Megarbane; N Bigé; N Brulé; A S Moreau; A Lautrette; O Peyrony; P Perez; J Mayaux; E Azoulay
Journal:  Ann Intensive Care       Date:  2018-08-13       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.